mRNA |
TAK-715 |
GDSC1000 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.3 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |